{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T18:27:11Z","timestamp":1788805631827,"version":"build-2803163510"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["302153\/2019-5"],"award-info":[{"award-number":["302153\/2019-5"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004901","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de Minas Gerais","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1007\/s00467-020-04762-6","type":"journal-article","created":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T05:44:04Z","timestamp":1601531044000},"page":"2203-2215","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Hepatorenal syndrome in children: a review"],"prefix":"10.1007","volume":"36","author":[{"given":"Priscila Menezes Ferri","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah Tayn\u00e1","family":"de Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pollyanna Faria","family":"Fradico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Luiza Barreto","family":"Cazumb\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramon Gustavo Bernardino","family":"Campos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9222-3882","authenticated-orcid":false,"given":"Ana Cristina","family":"Sim\u00f5es e Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,1]]},"reference":[{"key":"4762_CR1","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1016\/S0140-6736(03)14903-3","volume":"362","author":"P Gin\u00e8s","year":"2003","unstructured":"Gin\u00e8s P, Guevara M, Arroyo V, Rod\u00e9s J (2003) Hepatorenal syndrome. Lancet 362:1819\u20131827. https:\/\/doi.org\/10.1016\/S0140-6736(03)14903-3","journal-title":"Lancet"},{"key":"4762_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2165\/00148581-200608010-00001","volume":"8","author":"D Debray","year":"2006","unstructured":"Debray D, Yousef N, Durand P (2006) New management options for end-stage chronic liver disease and acute liver failure: potential for pediatric patients. Paediatr Drugs 8:1\u201313. https:\/\/doi.org\/10.2165\/00148581-200608010-00001","journal-title":"Paediatr Drugs"},{"key":"4762_CR3","doi-asserted-by":"publisher","first-page":"2512","DOI":"10.3748\/wjg.15.2512","volume":"15","author":"WW Vilas-Boas","year":"2009","unstructured":"Vilas-Boas WW, Ribeiro-Oliveira A Jr, Pereira RM, Ribeiro RC, Almeida J, Nadu AP, Sim\u00f5es e Silva AC, Santos RAS (2009) Relationship between angiotensin-(1-7) and angiotensin II correlates with hemodynamic changes in human liver cirrhosis. World J Gastroenterol 15:2512\u20132519. https:\/\/doi.org\/10.3748\/wjg.15.2512","journal-title":"World J Gastroenterol"},{"key":"4762_CR4","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1097\/MPG.0b013e3181d60e73","volume":"51","author":"N Yousef","year":"2010","unstructured":"Yousef N, Habes D, Ackermann O, Durand P, Bernard O, Jacquemin E (2010) Hepatorenal syndrome: diagnosis and effect of terlipressin therapy in 4 pediatric patients. J Pediatr Gastroenterol Nutr 51:100\u2013102. https:\/\/doi.org\/10.1097\/MPG.0b013e3181d60e73","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"4762_CR5","doi-asserted-by":"publisher","first-page":"e427","DOI":"10.3928\/19382359-20161117-01","volume":"45","author":"J Cordova","year":"2016","unstructured":"Cordova J, Jericho H, Azzam RK (2016) An overview of cirrhosis in children. Pediatr Ann 45:e427\u2013e432. https:\/\/doi.org\/10.3928\/19382359-20161117-01","journal-title":"Pediatr Ann"},{"key":"4762_CR6","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.disamonth.2016.05.009","volume":"62","author":"N Shah","year":"2016","unstructured":"Shah N, Silva RG, Kowalski A, Desai C, Lerma E (2016) Hepatorenal syndrome. Dis Mon 62:364\u2013375. https:\/\/doi.org\/10.1016\/j.disamonth.2016.05.009","journal-title":"Dis Mon"},{"key":"4762_CR7","doi-asserted-by":"publisher","first-page":"251","DOI":"10.4254\/wjh.v5.i5.251","volume":"5","author":"CM Moore","year":"2013","unstructured":"Moore CM, Van Thiel DH (2013) Cirrhotic ascites review: pathophysiology, diagnosis andmanagement. World J Hepatol 5:251. https:\/\/doi.org\/10.4254\/wjh.v5.i5.251","journal-title":"World J Hepatol"},{"key":"4762_CR8","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1002\/hep.1840080532","volume":"8","author":"RW Schrier","year":"1988","unstructured":"Schrier RW, Arroyo V, Bernardi M, Epstein M, Henriksen JH, Rod\u00e9s J (1988) Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology 8:1151\u20131157. https:\/\/doi.org\/10.1002\/hep.1840080532","journal-title":"Hepatology"},{"key":"4762_CR9","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1007\/BF00863460","volume":"10","author":"G Van Roey","year":"1996","unstructured":"Van Roey G, Moore K (1996) The hepatorenal syndrome. Pediatr Nephrol 10:100\u2013107. https:\/\/doi.org\/10.1007\/BF00863460","journal-title":"Pediatr Nephrol"},{"key":"4762_CR10","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1002\/hep.510280405","volume":"28","author":"TK Gupta","year":"1998","unstructured":"Gupta TK, Toruner M, Chung MK, Groszmann RJ (1998) Endothelial dysfunction and decreased production of nitric oxide in the intrahepatic microcirculation of cirrhotic rats. Hepatology 28:926\u2013931. https:\/\/doi.org\/10.1002\/hep.510280405","journal-title":"Hepatology"},{"key":"4762_CR11","doi-asserted-by":"publisher","first-page":"G1043","DOI":"10.1152\/ajpgi.1999.276.4.G1043","volume":"276","author":"R Wiest","year":"1999","unstructured":"Wiest R, Shah V, Sessa WC, Groszmann RJ (1999) NO overproduction by eNOS precedes hyperdynamic splanchnic circulation in portal hypertensive rats. Am J Phys 276:G1043\u2013G1051. https:\/\/doi.org\/10.1152\/ajpgi.1999.276.4.G1043","journal-title":"Am J Phys"},{"key":"4762_CR12","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/S0168-8278(05)80156-4","volume":"20","author":"JM Pak","year":"1994","unstructured":"Pak JM, Lee SS (1994) Glucagon in portal hypertension. J Hepatol 20:825\u2013832. https:\/\/doi.org\/10.1016\/S0168-8278(05)80156-4","journal-title":"J Hepatol"},{"key":"4762_CR13","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.jhep.2010.08.013","volume":"54","author":"M Di Pascoli","year":"2011","unstructured":"Di Pascoli M, Zampieri F, Quarta S, Sacerdoti D, Merkel C, Gatta A, Bolognesi M (2011) Heme oxygenase regulates renal arterial resistance and sodium excretion in cirrhotic rats. J Hepatol 54:258\u2013264. https:\/\/doi.org\/10.1016\/j.jhep.2010.08.013","journal-title":"J Hepatol"},{"key":"4762_CR14","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1159\/000462974","volume":"54","author":"M Di Pascoli","year":"2017","unstructured":"Di Pascoli M, Sacerdoti D, Pontisso P, Angeli P, Bolognesi M (2017) Molecular mechanism leading to splanchnic vasodilation in liver cirrhosis. J Vasc Res 54:92\u201399. https:\/\/doi.org\/10.1159\/000462974","journal-title":"J Vasc Res"},{"key":"4762_CR15","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1002\/hep.510290621","volume":"29","author":"M Fernandez","year":"1999","unstructured":"Fernandez M, Bonkovsky HL (1999) Increased heme oxygenase-1 gene expression in liver cells and splanchnic organs from portal hypertensive rats. Hepatology 29:1672\u20131679. https:\/\/doi.org\/10.1002\/hep.510290621","journal-title":"Hepatology"},{"key":"4762_CR16","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1124\/jpet.106.116665","volume":"321","author":"M Bolognesi","year":"2007","unstructured":"Bolognesi M, Sacerdoti D, Piva A, Di Pascoli M, Zampieri F, Quarta S, Motterlini R, Angeli P, Merkel C, Gatta A (2007) Carbon monoxide-mediated activation of large-conductance calcium-activated potassium channels contributes to mesenteric vasodilatation in cirrhotic rats. J Pharmacol Exp Ther 321:187\u2013194. https:\/\/doi.org\/10.1124\/jpet.106.116665","journal-title":"J Pharmacol Exp Ther"},{"key":"4762_CR17","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1016\/0016-5085(91)90284-r","volume":"100","author":"K Moore","year":"1991","unstructured":"Moore K, Ward PS, Taylor GW, Williams R (1991) Systemic and renal production of thromboxane A2 and prostacyclin in decompensated liver disease and hepatorenal syndrome. Gastroenterology 100:1069\u20131077. https:\/\/doi.org\/10.1016\/0016-5085(91)90284-r","journal-title":"Gastroenterology"},{"key":"4762_CR18","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/0952-3278(95)90081-0","volume":"53","author":"M Ohta","year":"1995","unstructured":"Ohta M, Kishihara F, Hashizume M, Kawanaka H, Tomikawa M, Higashi H, Tanoue K, Sugimachi K (1995) Increased prostacyclin content in gastric mucosa of cirrhotic patients with portal hypertensive gastropathy. Prostaglandins Leukot Essent Fatty Acids 53:41\u201345. https:\/\/doi.org\/10.1016\/0952-3278(95)90081-0","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"4762_CR19","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.prostaglandins.2015.05.008","volume":"120","author":"D Sacerdoti","year":"2015","unstructured":"Sacerdoti D, Pesce P, Di Pascoli M, Brocco S, Cecchetto L, Bolognesi M (2015) Arachidonic acid metabolites and endothelial dysfunction of portal hypertension. Prostaglandins Other Lipid Mediat 120:80\u201390. https:\/\/doi.org\/10.1016\/j.prostaglandins.2015.05.008","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"4762_CR20","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.prostaglandins.2016.06.002","volume":"125","author":"D Sacerdoti","year":"2016","unstructured":"Sacerdoti D, Pesce P, Di Pascoli M, Bolognesi M (2016) EETs and HO-1 crosstalk. Prostaglandins Other Lipid Mediat 125:65\u201379. https:\/\/doi.org\/10.1016\/j.prostaglandins.2016.06.002","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"4762_CR21","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1038\/89953","volume":"7","author":"S B\u00e1tkai","year":"2001","unstructured":"B\u00e1tkai S, J\u00e1rai Z, Wagner JA, Goparaju SK, Varga K, Liu J, Wang L, Mirshahi F, Khanolkar AD, Makriyannis A, Urbaschek R, Garcia N Jr, Sanyal AJ, Kunos G (2001) Endocannabinoids acting at vascular CB 1 receptors mediate the vasodilated state in advanced liver cirrhosis. Nat Med 7:827\u2013832. https:\/\/doi.org\/10.1038\/89953","journal-title":"Nat Med"},{"key":"4762_CR22","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1136\/gut.2004.051599","volume":"54","author":"M Domenicali","year":"2005","unstructured":"Domenicali M, Ros J, Fern\u00e1ndez-Varo G, Cejudo-Martin P, Crespo M, Morales-Ruiz M, Briones AM, Campistol J-M, Arroyo V, Vila E, Rod\u00e9s J, Jim\u00e9nez W (2005) Increased anandamide induced relaxation in mesenteric arteries of cirrhotic rats: role of cannabinoid and vanilloid receptors. Gut 54:522\u2013527. https:\/\/doi.org\/10.1136\/gut.2004.051599","journal-title":"Gut"},{"key":"4762_CR23","doi-asserted-by":"publisher","first-page":"H885","DOI":"10.1152\/ajpheart.1988.255.4.H885","volume":"255","author":"N Rossi","year":"1988","unstructured":"Rossi N, Churchill P, Ellis V, Amore B (1988) Mechanism of adenosine receptor-induced renal vasoconstriction in rats. Am J Phys 255:H885\u2013H890. https:\/\/doi.org\/10.1152\/ajpheart.1988.255.4.H885","journal-title":"Am J Phys"},{"key":"4762_CR24","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1055\/s-2008-1040611","volume":"6","author":"JN Benoit","year":"1986","unstructured":"Benoit JN, Granger DN (1986) Splanchnic hemodynamics in chronic portal hypertension. Semin Liver Dis 6:287\u2013298. https:\/\/doi.org\/10.1055\/s-2008-1040611","journal-title":"Semin Liver Dis"},{"key":"4762_CR25","doi-asserted-by":"publisher","first-page":"G52","DOI":"10.1152\/ajpgi.1983.244.1.G52","volume":"244","author":"J Vorobioff","year":"1983","unstructured":"Vorobioff J, Bredfeldt JE, Groszmann RJ (1983) Hyperdynamic circulation in portalhypertensive rat model: a primary factor for maintenance of chronic portal hypertension. Am J Phys 244:G52\u2013G57. https:\/\/doi.org\/10.1152\/ajpgi.1983.244.1.G52","journal-title":"Am J Phys"},{"key":"4762_CR26","doi-asserted-by":"publisher","first-page":"081","DOI":"10.1055\/s-2008-1040323","volume":"28","author":"V Arroyo","year":"2008","unstructured":"Arroyo V, Fernandez J, Gines P (2008) Pathogenesis and treatment of hepatorenal syndrome. Semin Liver Dis 28:081\u2013095. https:\/\/doi.org\/10.1055\/s-2008-1040323","journal-title":"Semin Liver Dis"},{"key":"4762_CR27","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1053\/jhep.2003.50447","volume":"38","author":"L Ruiz-del-Arbol","year":"2003","unstructured":"Ruiz-del-Arbol L, Urman J, Fern\u00e1ndez J, Gonz\u00e1lez M, Navasa M, Monescillo A, Albillos A, Jim\u00e9nez W, Arroyo V (2003) Systemic, renal, and hepatic hemodynamic derangement in cirrhotic patients with spontaneous bacterial peritonitis. Hepatology 38:1210\u20131218. https:\/\/doi.org\/10.1053\/jhep.2003.50447","journal-title":"Hepatology"},{"key":"4762_CR28","doi-asserted-by":"publisher","first-page":"125","DOI":"10.2174\/157016111201140327163930","volume":"12","author":"B Barbano","year":"2014","unstructured":"Barbano B, Sardo L, Gigante A, Ludovica Gasperini M, Liberatori M, Di Lazzaro G, Lacanna A, Amoroso A, Cianci R (2014) Pathophysiology, diagnosis and clinical management of hepatorenal syndrome: from classic to new drugs. Curr Vasc Pharmacol 12:125\u2013135. https:\/\/doi.org\/10.2174\/157016111201140327163930","journal-title":"Curr Vasc Pharmacol"},{"key":"4762_CR29","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/j.jhep.2007.02.001","volume":"46","author":"V Arroyo","year":"2007","unstructured":"Arroyo V, Terra C, Gin\u00e8s P (2007) Advances in the pathogenesis and treatment of type-1 and type-2 hepatorenal syndrome. J Hepatol 46:935\u2013946. https:\/\/doi.org\/10.1016\/j.jhep.2007.02.001","journal-title":"J Hepatol"},{"key":"4762_CR30","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1002\/hep.20766","volume":"42","author":"L Ruiz-del-Arbol","year":"2005","unstructured":"Ruiz-del-Arbol L, Monescillo A, Arocena C, Valer P, Gines P, Moreira V, Milicua M, Jim\u00e9nez W, Arroyo V (2005) Circulatory function and hepatorenal syndrome in cirrhosis. Hepatology 42:439\u2013447. https:\/\/doi.org\/10.1002\/hep.20766","journal-title":"Hepatology"},{"key":"4762_CR31","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1002\/hep.510280107","volume":"28","author":"M Guevara","year":"1998","unstructured":"Guevara M, Bru C, Gin\u00e8s P, Fern\u00e1ndez-Esparrach G, Sort P, Bataller R, Jim\u00e9nez W, Arroyo V, Rod\u00e9s J (1998) Increased cerebrovascular resistance in cirrhotic patients with ascites. Hepatology 28:39\u201344. https:\/\/doi.org\/10.1002\/hep.510280107","journal-title":"Hepatology"},{"key":"4762_CR32","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S0168-8278(87)80569-X","volume":"5","author":"JA Solis-Herruzo","year":"1987","unstructured":"Solis-Herruzo JA, Duran A, Favela V, Castellano G, Madrid JL, Mu\u00f1oz-Yag\u00fce MT, Morillas JD, Estenoz J (1987) Effects of lumbar sympathetic block on kidney function in cirrhotic patients with hepatorenal syndrome. J Hepatol 5:167\u2013173. https:\/\/doi.org\/10.1016\/S0168-8278(87)80569-X","journal-title":"J Hepatol"},{"key":"4762_CR33","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.jhep.2007.03.008","volume":"47","author":"CB Herath","year":"2007","unstructured":"Herath CB, Warner FJ, Lubel JS, Dean RG, Jia Z, Lew RA, Smith AI, Burrell LM, Angus PW (2007) Upregulation of hepatic angiotensin-converting enzyme 2 (ACE2) and angiotensin- (1\u20137) levels in experimental biliary fibrosis. J Hepatol 47:387\u2013395. https:\/\/doi.org\/10.1016\/j.jhep.2007.03.008","journal-title":"J Hepatol"},{"key":"4762_CR34","doi-asserted-by":"publisher","first-page":"33238","DOI":"10.1074\/jbc.M002615200","volume":"275","author":"SR Tipnis","year":"2000","unstructured":"Tipnis SR, Hooper NM, Hyde R, Karran E, Christie G, Turner AJ (2000) A human homolog of angiotensin-converting enzyme cloning and functional expression as a captopril-insensitive carboxypeptidase. J Biol Chem 275:33238\u201333243. https:\/\/doi.org\/10.1074\/jbc.M002615200","journal-title":"J Biol Chem"},{"key":"4762_CR35","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1161\/01.res.87.5.e1","volume":"87","author":"M Donoghue","year":"2000","unstructured":"Donoghue M, Hsieh F, Baronas E, Godbout K, Gosselin M, Stagliano N, Donovan M, Woolf B, Robison K, Jeyaseelan R, Acton S, Breitbart RE (2000) A novel angiotensin-converting enzyme\u2013related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circ Res 87:e1\u2013e9. https:\/\/doi.org\/10.1161\/01.res.87.5.e1","journal-title":"Circ Res"},{"key":"4762_CR36","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.phrs.2016.03.018","volume":"107","author":"AC Sim\u00f5es e Silva","year":"2016","unstructured":"Sim\u00f5es e Silva AC, Teixeira MM (2016) ACE inhibition, ACE2 and angiotensin-(1-7) axis in kidneyand cardiac inflammation and fibrosis. Pharmacol Res 107:154\u2013162. https:\/\/doi.org\/10.1016\/j.phrs.2016.03.018","journal-title":"Pharmacol Res"},{"key":"4762_CR37","doi-asserted-by":"publisher","first-page":"8258","DOI":"10.1073\/pnas.1432869100","volume":"100","author":"RA Santos","year":"2003","unstructured":"Santos RA, Sim\u00f5es e Silva AC, Maric C, Silva DM, Machado RP, de Buhr I, Heringer-Walther S, Pinheiro SVB, Lopes MT, Bader M, Lemos VS, Campagnole-Santos MJ, Schultheiss HP, Speth R, Walther T, Mendes EP (2003) Angiotensin-(1\u20137) is an endogenous ligand for the G protein-coupled receptor mas. Proc Natl Acad Sci U S A 100:8258\u20138263. https:\/\/doi.org\/10.1073\/pnas.1432869100","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4762_CR38","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1136\/gut.2004.062398","volume":"54","author":"G Paizis","year":"2005","unstructured":"Paizis G, Tikellis C, Cooper ME, Schembri JM, Lew RA, Smith AI, Shaw T, Warner FJ, Zuilli A, Burrell LM, Angus PW (2005) Chronic liver injury in rats and humans upregulates the novel enzyme angiotensin converting enzyme 2. Gut 54:1790\u20131796. https:\/\/doi.org\/10.1136\/gut.2004.062398","journal-title":"Gut"},{"key":"4762_CR39","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1111\/bph.12159","volume":"169","author":"AC Sim\u00f5es e Silva","year":"2013","unstructured":"Sim\u00f5es e Silva AC, Silveira KD, Ferreira AJ, Teixeira MM (2013) ACE2, angiotensin- (1-7) and M as receptor axis in inflammation and fibrosis. Br J Pharmacol 169:477\u2013492. https:\/\/doi.org\/10.1111\/bph.12159","journal-title":"Br J Pharmacol"},{"key":"4762_CR40","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1161\/01.HYP.27.4.875","volume":"27","author":"RA Santos","year":"1996","unstructured":"Santos RA, Sim\u00f5es e Silva AC, Magaldi AJ, Khosla MC, Cesar KR, Passaglio KT, Baracho NC (1996) Evidence for a physiological role of angiotensin-(1-7) in the control of hydroelectrolyte balance. Hypertension 27:875\u2013884. https:\/\/doi.org\/10.1161\/01.HYP.27.4.875","journal-title":"Hypertension"},{"key":"4762_CR41","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1590\/S0100-879X1997000400012","volume":"30","author":"AC Sim\u00f5es e Silva","year":"1997","unstructured":"Sim\u00f5es e Silva AC, Baracho NCV, Passaglio KT, Santos RAS (1997) Renal actions of angiotensin-(1-7). Braz J Med Biol Res 30:503\u2013513. https:\/\/doi.org\/10.1590\/S0100-879X1997000400012","journal-title":"Braz J Med Biol Res"},{"key":"4762_CR42","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s00424-003-1173-1","volume":"447","author":"AJ Magaldi","year":"2003","unstructured":"Magaldi AJ, Cesar KR, de Ara\u00fajo M, Sim\u00f5es e Silva AC, Santos RA (2003) Angiotensin-(1\u20137) stimulates water transport in rat inner medullary collecting duct: evidence for involvement of vasopressin V 2 receptors. Pflugers Arch 447:223\u2013230. https:\/\/doi.org\/10.1007\/s00424-003-1173-1","journal-title":"Pflugers Arch"},{"key":"4762_CR43","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1038\/ki.1993.334","volume":"44","author":"S Andreatta-van Leyen","year":"1993","unstructured":"Andreatta-van Leyen S, Romero MF, Khosla MC, Douglas JG (1993) Modulation of phospholipase A2 activity and sodium transport by angiotensin-(1-7). Kidney Int 44:932\u2013936. https:\/\/doi.org\/10.1038\/ki.1993.334","journal-title":"Kidney Int"},{"key":"4762_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1476-5381.1994.tb14014.x","volume":"111","author":"A DelliPizzi","year":"1994","unstructured":"DelliPizzi A, Hilchey SD, Bell-Quilley CP (1994) Natriuretic action of angiotensin (1\u2013 7). Br J Pharmacol 111:1\u20133. https:\/\/doi.org\/10.1111\/j.1476-5381.1994.tb14014.x","journal-title":"Br J Pharmacol"},{"key":"4762_CR45","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.abb.2010.02.005","volume":"496","author":"LS Lara","year":"2010","unstructured":"Lara LS, Vives D, Correa JS, Cardozo FP, Marques-Fernades MF, Lopes AG, Caruso-Neves C (2010) PKA-mediated effect of MAS receptor in counteracting angiotensin II-stimulated renal Na+-ATPase. Arch Biochem Biophys 496:117\u2013122. https:\/\/doi.org\/10.1016\/j.abb.2010.02.005","journal-title":"Arch Biochem Biophys"},{"key":"4762_CR46","doi-asserted-by":"publisher","first-page":"3396","DOI":"10.3748\/wjg.v23.i19.3396","volume":"23","author":"ACS Sim\u00f5es e Silva","year":"2017","unstructured":"Sim\u00f5es e Silva ACS, Miranda AS, Rocha NP, Teixeira AL (2017) Renin angiotensin system in liver diseases: friend or foe? World J Gastroenterol 23:3396\u20133406. https:\/\/doi.org\/10.3748\/wjg.v23.i19.3396","journal-title":"World J Gastroenterol"},{"key":"4762_CR47","doi-asserted-by":"publisher","first-page":"H1985","DOI":"10.1152\/ajpheart.01145.2002","volume":"284","author":"WO Sampaio","year":"2003","unstructured":"Sampaio WO, Nascimento AA, Santos RA (2003) Systemic and regional hemodynamic effects of angiotensin-(1\u20137) in rats. Am J Physiol Heart Circ Physiol 284:H1985\u2013H1994. https:\/\/doi.org\/10.1152\/ajpheart.01145.2002","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"4762_CR48","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1161\/hy0302.104673","volume":"39","author":"Y Ren","year":"2002","unstructured":"Ren Y, Garvin JL, Carretero OA (2002) Vasodilator action of angiotensin-(1-7) on isolated rabbit afferent arterioles. Hypertension 39:799\u2013802. https:\/\/doi.org\/10.1161\/hy0302.104673","journal-title":"Hypertension"},{"key":"4762_CR49","doi-asserted-by":"publisher","first-page":"H2485","DOI":"10.1152\/ajpheart.01245.2006","volume":"292","author":"GA Botelho-Santos","year":"2007","unstructured":"Botelho-Santos GA, Sampaio WO, Reudelhuber TL, Bader M, Campagnole-Santos MJ, Souza dos Santos RA (2007) Expression of an angiotensin-(1-7)-producing fusion protein in rats induced marked changes in regional vascular resistance. Am J Physiol Heart Circ Physiol 292:H2485\u2013H2490. https:\/\/doi.org\/10.1152\/ajpheart.01245.2006","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"4762_CR50","doi-asserted-by":"publisher","first-page":"3197","DOI":"10.3748\/wjg.v21.i11.3197","volume":"21","author":"S John","year":"2015","unstructured":"John S, Thuluvath PJ (2015) Hyponatremia in cirrhosis: pathophysiology and management. World J Gastroenterol 21:3197\u20133205. https:\/\/doi.org\/10.3748\/wjg.v21.i11.3197","journal-title":"World J Gastroenterol"},{"key":"4762_CR51","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/0016-5085(91)90222-7","volume":"100","author":"J Claria","year":"1991","unstructured":"Claria J, Jim\u00e9nez W, Arroyo V, La Villa G, L\u00f3pez C, Asbert M, Castro A, Gaya J, Rivera F, Rod\u00e9s J (1991) Effect of V1-vasopressin receptor blockade on arterial pressure in conscious rats with cirrhosis and ascites. Gastroenterology 100:494\u2013501. https:\/\/doi.org\/10.1016\/0016-5085(91)90222-7","journal-title":"Gastroenterology"},{"key":"4762_CR52","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1056\/NEJM199212173272502","volume":"327","author":"K Moore","year":"1992","unstructured":"Moore K, Wendon J, Frazer M, Karani J, Williams R, Badr K (1992) Plasma endothelin immunoreactivity in liver disease and the hepatorenal syndrome. N Engl J Med 327:1774\u20131778. https:\/\/doi.org\/10.1056\/NEJM199212173272502","journal-title":"N Engl J Med"},{"key":"4762_CR53","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1111\/j.1432-2277.2000.tb01010.x","volume":"13","author":"S Bachmann-Brandt","year":"2000","unstructured":"Bachmann-Brandt S, Bittner I, Neuhaus P, Frei U, Schindler R (2000) Plasma levels of endothelin- 1 in patients with the hepatorenal syndrome after successful liver transplantation. Transpl Int 13:357\u2013362. https:\/\/doi.org\/10.1111\/j.1432-2277.2000.tb01010.x","journal-title":"Transpl Int"},{"key":"4762_CR54","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/0168-8278(90)90123-9","volume":"11","author":"KP Moore","year":"1990","unstructured":"Moore KP, Taylor GW, Maltby NH, Siegers D, Fuller RW, Dollery CT, Williams R (1990) Increased production of cysteinyl leukotrienes in hepatorenal syndrome. J Hepatol 11:263\u2013271. https:\/\/doi.org\/10.1016\/0168-8278(90)90123-9","journal-title":"J Hepatol"},{"key":"4762_CR55","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1111\/j.1365-2362.1989.tb00195.x","volume":"19","author":"M Huber","year":"1989","unstructured":"Huber M, K\u00e4stner S, Sch\u00f6lmerich J, Gerok W, Keppler D (1989) Analysis of cysteinyl leukotrienes in human urine: enhanced excretion in patients with liver cirrhosis and hepatorenal syndrome. Eur J Clin Investig 19:53\u201360. https:\/\/doi.org\/10.1111\/j.1365-2362.1989.tb00195.x","journal-title":"Eur J Clin Investig"},{"key":"4762_CR56","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1002\/hep.1840200619","volume":"20","author":"A Follo","year":"1994","unstructured":"Follo A, Llovet JM, Navasa M, Planas R, Forns X, Francitorra A, Rimola A, Gassull MA, Arroyo V, Rod\u00e9s J (1994) Renal impairment after spontaneous bacterial peritonitis in cirrhosis: incidence, clinical course, predictive factors and prognosis. Hepatology 20:1495\u20131501. https:\/\/doi.org\/10.1002\/hep.1840200619","journal-title":"Hepatology"},{"key":"4762_CR57","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1002\/hep.1840170215","volume":"17","author":"C Toledo","year":"1993","unstructured":"Toledo C, Salmer\u00f3n JM, Rimola A, Navasa M, Arroyo V, Llach J, Gin\u00e9s A, Gin\u00e8s P, Rod\u00e9s J (1993) Spontaneous bacterial peritonitis in cirrhosis: predictive factors of infection resolution and survival in patients treated with cefotaxime. Hepatology 17:251\u2013257. https:\/\/doi.org\/10.1002\/hep.1840170215","journal-title":"Hepatology"},{"key":"4762_CR58","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/0016-5085(93)90031-7","volume":"105","author":"A Gin\u00e8s","year":"1993","unstructured":"Gin\u00e8s A, Escorsell A, Gin\u00e8s P, Sal\u00f3 J, Jim\u00e9nez W, Inglada L, Navasa M, Cl\u00e0ria J, Rimola A, Arroyo V, Rod\u00e9s J (1993) Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites. Gastroenterology 105:229\u2013236. https:\/\/doi.org\/10.1016\/0016-5085(93)90031-7","journal-title":"Gastroenterology"},{"key":"4762_CR59","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/j.mcna.2008.03.007","volume":"92","author":"SJ Munoz","year":"2008","unstructured":"Munoz SJ (2008) The hepatorenal syndrome. Med Clin North Am 92:813\u2013837. https:\/\/doi.org\/10.1016\/j.mcna.2008.03.007","journal-title":"Med Clin North Am"},{"key":"4762_CR60","doi-asserted-by":"publisher","first-page":"735","DOI":"10.7326\/0003-4819-144-10-200605160-00007","volume":"144","author":"BM McGuire","year":"2006","unstructured":"McGuire BM, Julian BA, Bynon JJS, Cook WJ, King SJ, Curtis JJ, Accortt NA, Eckhoff DE (2006) Brief communication: glomerulonephritis in patients with hepatitis C cirrhosis undergoing liver transplantation. Ann Intern Med 144:735\u2013741. https:\/\/doi.org\/10.7326\/0003-4819-144-10-200605160-00007","journal-title":"Ann Intern Med"},{"key":"4762_CR61","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s00467-018-3893-7","volume":"34","author":"A Deep","year":"2019","unstructured":"Deep A, Saxena R, Jose B (2019) Acute kidney injury in children with chronic liver disease. Pediatr Nephrol 34:45\u201359. https:\/\/doi.org\/10.1007\/s00467-018-3893-7","journal-title":"Pediatr Nephrol"},{"key":"4762_CR62","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.1002\/hep.22605","volume":"48","author":"G Garcia-Tsao","year":"2008","unstructured":"Garcia-Tsao G, Parikh CR, Viola A (2008) Acute kidney injury in cirrhosis. Hepatology 48:2064\u20132077","journal-title":"Hepatology"},{"key":"4762_CR63","doi-asserted-by":"publisher","first-page":"293","DOI":"10.4254\/wjh.v9.i6.293","volume":"9","author":"JG Acevedo","year":"2017","unstructured":"Acevedo JG, Cramp ME (2017) Hepatorenal syndrome: update on diagnosis and therapy. World J Hepatol 9:293\u2013299. https:\/\/doi.org\/10.4254\/wjh.v9.i6.293","journal-title":"World J Hepatol"},{"key":"4762_CR64","doi-asserted-by":"publisher","unstructured":"Govindan S, Venkataraman C (2019) Hepatorenal syndrome in children: diagnosis and management. Pediatric Liver Intensive Care:49\u201352. https:\/\/doi.org\/10.1007\/978-981-13-1304-2_7","DOI":"10.1007\/978-981-13-1304-2_7"},{"key":"4762_CR65","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1136\/gutjnl-2014-308874","volume":"64","author":"P Angeli","year":"2015","unstructured":"Angeli P, Gin\u00e8s P, Wong F, Bernardi M, Boyer TD, Gerbes A, Moreau R, Jalan R, Sarin SK, Piano S, Lee SS, Durand F, Salerno F, Caraceni P, Kim WR, Arroyo V, Garcia-Tsao G, Moore K (2015) Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites. Gut 64:531\u2013537. https:\/\/doi.org\/10.1136\/gutjnl-2014-308874","journal-title":"Gut"},{"key":"4762_CR66","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.jhep.2010.11.020","volume":"55","author":"TD Boyer","year":"2011","unstructured":"Boyer TD, Sanyal AJ, Garcia-Tsao G, Blei A, Carl D, Bexon AS, Teuber P, Terlipressin Study Group (2011) Predictors of response to terlipressin plus albumin in hepatorenal syndrome (HRS) type 1: relationship of serum creatinine to hemodynamics. J Hepatol 55:315\u2013321. https:\/\/doi.org\/10.1016\/j.jhep.2010.11.020","journal-title":"J Hepatol"},{"key":"4762_CR67","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/j.jhep.2019.07.002","volume":"71","author":"P Angeli","year":"2019","unstructured":"Angeli P, Garcia-Tsao G, Nadim MK, Parikh CR (2019) News in pathophysiology, definition and classification of hepatorenal syndrome: a step beyond the International Club of Ascites (ICA) consensus document. J Hepatol 71:811\u2013822. https:\/\/doi.org\/10.1016\/j.jhep.2019.07.002","journal-title":"J Hepatol"},{"key":"4762_CR68","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1002\/lt.22395","volume":"17","author":"TD Boyer","year":"2011","unstructured":"Boyer TD, Sanyal AJ, Garcia-Tsao G, Regenstein F, Rossaro L, Appenrodt B, G\u00fcilberg V, Sigal S, Bexon AS, Teuber P, Terlipressin Study Group (2011) Impact of liver transplantation on the survival of patients treated for hepatorenal syndrome type 1. Liver Transpl 17:1328\u20131332. https:\/\/doi.org\/10.1002\/lt.22395","journal-title":"Liver Transpl"},{"key":"4762_CR69","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1053\/jhep.2002.33160","volume":"35","author":"S Nair","year":"2002","unstructured":"Nair S, Verma S, Thuluvath PJ (2002) Pretransplant renal function predicts survival in patients undergoing orthotopic liver transplantation. Hepatology 35:1179\u20131185. https:\/\/doi.org\/10.1053\/jhep.2002.33160","journal-title":"Hepatology"},{"key":"4762_CR70","doi-asserted-by":"publisher","first-page":"277","DOI":"10.5527\/wjn.v4.i2.277","volume":"4","author":"HZ Dundar","year":"2015","unstructured":"Dundar HZ, Y\u0131lmazlar T (2015) Management of hepatorenal syndrome. World J Nephrol 4:277. https:\/\/doi.org\/10.5527\/wjn.v4.i2.277","journal-title":"World J Nephrol"},{"key":"4762_CR71","doi-asserted-by":"publisher","first-page":"S93","DOI":"10.1016\/j.jhep.2008.01.010","volume":"48","author":"P Angeli","year":"2008","unstructured":"Angeli P, Merkel C (2008) Pathogenesis and management of hepatorenal syndrome in patients with cirrhosis. J Hepatol 48:S93\u2013S103. https:\/\/doi.org\/10.1016\/j.jhep.2008.01.010","journal-title":"J Hepatol"},{"key":"4762_CR72","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.jhep.2003.09.019","volume":"40","author":"T Restuccia","year":"2004","unstructured":"Restuccia T, Ortega R, Guevara M, Gin\u00e8s P, Alessandria C, Ozdogan O, Navasa M, Rimola A, Garcia-Valdecasas JC, Arroyo V, Rod\u00e9s J (2004) Effects of treatment of hepatorenal syndrome before transplantation on posttransplantation outcome. A case-control study. J Hepatol 40:140\u2013146. https:\/\/doi.org\/10.1016\/j.jhep.2003.09.019","journal-title":"J Hepatol"},{"key":"4762_CR73","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.semnephrol.2018.10.002","volume":"39","author":"AA Amin","year":"2019","unstructured":"Amin AA, Alabsawy EI, Jalan R, Davenport A (2019) Epidemiology, pathophysiology, and management of hepatorenal syndrome. Semin Nephrol 39:17\u201330. https:\/\/doi.org\/10.1016\/j.semnephrol.2018.10.002","journal-title":"Semin Nephrol"},{"key":"4762_CR74","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1093\/gastro\/goz043","volume":"8","author":"L Wang","year":"2020","unstructured":"Wang L, Long Y, Li KX, Xu GS (2020) Pharmacological treatment of hepatorenal syndrome: a network meta-analysis. Gastroenterol Rep 8:111\u2013118. https:\/\/doi.org\/10.1093\/gastro\/goz043","journal-title":"Gastroenterol Rep"},{"key":"4762_CR75","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.jhep.2011.08.020","volume":"56","author":"A C\u00e1rdenas","year":"2012","unstructured":"C\u00e1rdenas A, Gin\u00e8s P, Marotta P, Czerwiec F, Oyuang J, Guevara M, Afdhal NH (2012) Tolvaptan, an oral vasopressin antagonist, in the treatment of hyponatremia in cirrhosis. J Hepatol 56:571\u2013578","journal-title":"J Hepatol"},{"key":"4762_CR76","first-page":"334","volume":"17","author":"J Yuan","year":"2009","unstructured":"Yuan J, Ye Q, Zhang H, Ming Y, Gui M, Ji Y, Sun J, Wang JW, Ren ZH, Cheng K, Zhao YJ, Sun PL, Wu K, Ji LZ (2009) Evaluation of the renal replacement therapy on the liver transplant patients with acute renal failure. Zhonghua Gan Zang Bing Za Zhi 17:334\u2013337","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"key":"4762_CR77","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1007\/s00467-012-2348-9","volume":"28","author":"B Schaefer","year":"2013","unstructured":"Schaefer B, Schmitt CP (2013) The role of molecular adsorbent recirculating system dialysis for extracorporeal liver support in children. Pediatr Nephrol 28:1763\u20131769","journal-title":"Pediatr Nephrol"},{"key":"4762_CR78","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1111\/j.1525-1594.2006.00215.x","volume":"30","author":"P Evenepoel","year":"2006","unstructured":"Evenepoel P, Laleman W, Wilmer A, Claes K, Kuypers D, Bammens B, Nevens F, Vanrenterghem Y (2006) Prometheus versus molecular adsorbents recirculating system: comparison of efficiency in two different liver detoxification devices. Artif Organs 30:276\u2013284","journal-title":"Artif Organs"},{"key":"4762_CR79","doi-asserted-by":"publisher","unstructured":"Charilaou P, Devani K, Petrosyan R, Reddy C, Pyrsopoulos N (2020) Inpatient mortality benefit with transjugular intrahepatic portosystemic shunt for hospitalized hepatorenal syndrome patients. Dig Dis Sci. https:\/\/doi.org\/10.1007\/s10620-020-06136-2","DOI":"10.1007\/s10620-020-06136-2"},{"key":"4762_CR80","doi-asserted-by":"publisher","first-page":"2901","DOI":"10.1111\/j.1600-6143.2012.04190.x","volume":"12","author":"MK Nadim","year":"2012","unstructured":"Nadim MK, Sung RS, Davis CL, Andreoni KA, Biggins SW, Danovitch GM, Feng S, Friedewald JJ, Hong JC, Kellum JA, Kim WR, Lake JR, Melton LB, Pomfret EA, Saab S, Genyk YS (2012) Simultaneous liver\u2013kidney transplantation summit: current state and future directions. Am J Transplant 12:2901\u20132908","journal-title":"Am J Transplant"},{"key":"4762_CR81","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1097\/MPG.0000000000001862","volume":"66","author":"UB Berg","year":"2018","unstructured":"Berg UB, N\u00e9meth A (2018) Well preserved renal function in children with untreated chronic liver disease. J Pediatr Gastroenterol Nutr 66:575\u2013580. https:\/\/doi.org\/10.1097\/MPG.0000000000001862","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"4762_CR82","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1111\/liv.13693","volume":"38","author":"BB Lal","year":"2018","unstructured":"Lal BB, Alam S, Sood V, Rawat D, Khanna R (2018) Profile, risk factors and outcome of acute kidney injury in paediatric acute-on-chronic liver failure. Liver Int 38:1777\u20131784. https:\/\/doi.org\/10.1111\/liv.13693","journal-title":"Liver Int"},{"key":"4762_CR83","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1097\/MPG.0000000000001179","volume":"63","author":"S Alam","year":"2016","unstructured":"Alam S, Lal BB, Sood V, Rawat D (2016) Pediatric acute-on-chronic liver failure in a specialized liver unit: prevalence, profile, outcome, and predictive factors. J Pediatr Gastroenterol Nutr 63:400\u2013405. https:\/\/doi.org\/10.1097\/MPG.0000000000001179","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"4762_CR84","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1007\/s11894-015-0457-x","volume":"17","author":"RG Matloff","year":"2015","unstructured":"Matloff RG, Arnon R (2015) The kidney in pediatric liver disease. Curr Gastroenterol Rep 17:36. https:\/\/doi.org\/10.1007\/s11894-015-0457-x","journal-title":"Curr Gastroenterol Rep"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-020-04762-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00467-020-04762-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-020-04762-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T06:35:54Z","timestamp":1744180554000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00467-020-04762-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,1]]},"references-count":84,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["4762"],"URL":"https:\/\/doi.org\/10.1007\/s00467-020-04762-6","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,1]]},"assertion":[{"value":"12 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data availability"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}}]}}